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R
eferring to the article by Luijf et al.
(1), administrating rapid-acting
insulinanalogs15minbeforemeal-
times resulted in fewer episodes of post-
prandial hyperglycemia and more time
spent in the 3.5–1 0 . 0m m o l / Lr a n g e ,
without increased risk of hypoglycemia.
No effect was noted when administered
30 min before meals. Authors speculate
that if insulin administered 15 min before
the meal is optimum, then both 230 and
0 min treatment periods had an equal 15
min mismatch, resulting in almost equal
postprandial glycemic control.
In our opinion (2), it is a matter of
mimicking the “cephalic phase,” which
is lost in patients with type 1 diabetes. A
recent study (3) shows the mechanisms
and physiological relevance of the ce-
phalic insulin response to meal ingestion
in healthy subjects, attributed to auto-
nomic activation mediated by noncholin-
ergic and cholinergic mechanisms, lasts
for about 10 min, is initiated by meal
ingestion, and is required for normal
postprandial glucose tolerance (3).
In subjects with type 1 diabetes,
who have lost the endogenous insulin
secretion, it might be hypothesized that
by preceding a meal by an insulin bolus
injected 15 min before could replace this
“cephalic phase,” provided that the glyce-
mia before the meal is in the normal (1,2)
range. If the preprandial glycemia is above
the normal range, 15 min would not be
enough time to anticipate a normal post-
prandial response.Weobservedin69chil-
dren and adolescents (37 male and 32
female) aged 4–21 years (mean 6 SD
14.9 6 4.4 years), with type 1 diabetes for
8.4 6 4.5 years (BMI 21.8 6 4.1 m/kg
2,
insulin requirement 0.80 6 0.24 units/kg/
day, HbA1c 8.1 6 1.3%) undergoing TYpe
ofBOlusinchildrenwithDIabetes(TyBoDi)
studies (A.E.S., unpublished data) that
when the preprandial glycemia is above
10.0 mmol/L, injecting the bolus 15 min
prior to a meal is not sufﬁcient enough to
prevent60-,90-,120-minpostprandialhy-
perglycemia (11.2 6 1.9, 11.9 6 2.1, and
11.661.7mmol/L,respectively),irrespec-
tiveofthetypeofbolusused.Inthiscase,it
isbettertoinjectthebolus30–60minprior
to a meal. However, in our experience, to
separate the correction bolus from the meal
bolus has the following results: 230 min
experiment: premeal 11.2 6 1.9, 60 min
11.8 6 1.7, 90 min 11.5 6 1.7, and 120
min 10.8 6 2.2 mmol/L; 260 min experi-
ment: premeal 11.3 6 1.9, 60 min 10.8 6
3.1, 90 min 10.5 6 2.7, 120 min 10.3 6
2.7 mmol/L; separate bolus experiment (cor-
rectiongiven245andmealbolusgiven215
minpriormeal):premeal11.262.3,60min
8.7 62.7, 90 min 7.363.2,120min7.9 6
3.6 mmol/L; P 5 0.002 by ANOVA.
The observations reported by Luijf
et al. (1) and our group (2,4) demonstrate
that with new technology such as the in-
sulin pump and with new rapid-acting in-
sulin analogs, amount and timing of bolus
arebothimportantforpeoplewithdiabetes
toreachthegoalsoftheAmericanDiabetes
Association, the European Association for
theStudyofDiabetes,andtheInternational
SocietyforPediatricandAdolescentDiabe-
tes. Looking in depth into the daily habits
ofourpatientsmayshedlightontohowwe
can improve their glycemic control and,
most of all, quality of life. Further studies
are needed to evaluate the impact of differ-
enttypesofbolus(simplevs.double-wave)
for different types of meals with different
absorption times on glycemia.
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